Journal Article Summary
The article investigates the duration of dual antiplatelet therapy (DAPT) in patients who have undergone drug-eluting stent implantation following a ST-elevation myocardial infarction (STEMI). This topic is significant because DAPT is commonly prescribed to prevent blood clots after stent placement, but the optimal duration for treatment remains debated. Current guidelines suggest 12 months of DAPT for patients with acute myocardial infarction, but this study aims to determine if a shorter duration of six months could provide similar safety and efficacy outcomes for patients who remain event-free after the initial six months.
In this multicenter trial, 1,100 patients aged 18 to 85 who had STEMI and received a second-generation zotarolimus-eluting stent were enrolled. After six months, those who were event-free were randomly assigned to either continue DAPT for another six months or switch to single antiplatelet therapy (SAPT) with aspirin only. The results showed that the primary endpoint, which included all-cause mortality, myocardial infarction, revascularization, stroke, and major bleeding, occurred in 4.8% of the SAPT group compared to 6.6% in the DAPT group, indicating that six months of DAPT was non-inferior to 12 months.
However, the study has limitations, including a relatively low event rate and a design that only included patients who were event-free at six months, which may not represent the broader patient population. Patients should discuss the findings with their healthcare providers, especially considering the potential risks of bleeding associated with prolonged DAPT. While the study suggests that a shorter duration of DAPT may be safe for certain patients, individual circumstances and risks should guide treatment decisions.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Kedhi Elvin, Fabris Enrico, van der Ent Martin, Buszman Pawel, von Birgelen Clemens, Roolvink Vincent, Zurakowski Alexander, Schotborgh Carl E, et al.. Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial. The BMJ 2018. DOI: 10.1136/bmj.k3793. PMID: 30279197. PMCID: PMC6167608.
Featured Pill Pals Product
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over --- Generic For Bayer Low Dose --- Time Cap Labs --- Over The Counter
1000 (1,000) Count Low Dose Aspirin 81mg for Adults and Children 12 years and over — Generic For Bayer Low Dose — Time Cap Labs — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
